Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.

PloS one - 1 Jan 2020

Bokharaei-Salim Farah, Esghaei Maryam, Khanaliha Khadijeh, Kalantari Saeed, Marjani Arezoo, Fakhim Atousa, Keyvani Hossein

Abstract excerpt

BACKGROUND: The presence of drug resistance mutations (DRMs) against antiretroviral agents is one of the main concerns in the clinical management of individuals with human immunodeficiency virus-1 (HIV-1) infection, especially in regions of the world where treatment options are limited. The current study aimed at assessing the prevalence of HIV-1 DRMs among naïve and treatment-experienced HIV-1-infected patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Reverse Transcriptase Inhibitors

Share to Sequence Analysis, RNA

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 32119691
DOI: 10.1371/journal.pone.0229275
PMCID: PMC7051075

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.PMID 32119691Read ↗

HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of IranSemantic proximity Read ↗

A Surveillance on Protease Inhibitor Resistance-Associated Mutations Among Iranian HIV-1 PatientsSemantic proximity Read ↗

Human Immunodeficiency Virus-1 Drug Resistance Mutations in Iranian Treatment-experienced Individuals.Semantic proximity Read ↗

Antiretroviral drug resistance mutations in naïve and experienced patients in Shiraz, Iran, 2014.Semantic proximity Read ↗

Incidence and types of HIV-1 drug resistance mutation among patients failing first-line antiretroviral therapySemantic proximity Read ↗

Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.Semantic proximity Read ↗

HIV-1 Drug Resistance Profiles for the HIV Protease and Reverse Transcriptase Gene in Patients Receiving Combination Therapy in Tehran, Iran.Semantic proximity Read ↗

Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients.Semantic proximity Read ↗

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA PanelSemantic proximity Read ↗

HIV Drug Resistance and Phylogeny Profile in Naïve and Antiretroviral-Experienced Patients in Tehran, Iran.Semantic proximity Read ↗

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.Semantic proximity Read ↗

Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.